Compare Hims and Hers Health Inc (HIMS) vs Toronto-Dominion Bank (TD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs Toronto-Dominion Bank — how do they compare? Hims and Hers Health Inc trades at $30.92 (market cap $6.55B), while Toronto-Dominion Bank trades at $115.13 (market cap $185.79B). The key difference: Toronto-Dominion Bank is far larger — about 28.4× Hims and Hers Health Inc's market cap, and Toronto-Dominion Bank pays a 2.84% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hims and Hers Health Inc for 21 Days and Toronto-Dominion Bank for 84 Days on average.
| HIMS | TD | |
|---|---|---|
Market Cap | $6.55B | $185.79B |
Volume | 14,842,814 | 3,263,867 |
Sector | Health | Financials |
52-Week High | $62.76 | $124.80 |
52-Week Low | $14.52 | $78.32 |
Typical Hold Time | 21 Days | 84 Days |
Enterprise Value | $7.25B | $559.06B |
Dividend Yield | — | 2.84% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hims & Hers Health trades at $30.92, up 4.67% on the day, amid a bearish technical signal and significant legal headwinds from multiple securities class action lawsuits. The stock shows mixed fundamentals with strong revenue growth to $2.35 billion in 2025 but a sharp reversal to a net loss of -$142 million in 2026, reflecting profitability challenges. Valuation ratios appear elevated with a P/E of 57.14 and EV/EBITDA of 205.86, while analyst consensus remains cautiously optimistic with a $32.17 price target.
The outlook is clouded by legal risks and recent earnings misses, though the company's gross margin of 68.43% indicates underlying business strength. Investment opportunity hinges on resolving regulatory scrutiny and returning to profitability, but near-term volatility is likely. Key risks include the FTC lawsuit outcome and sustained negative cash flow, demanding careful risk assessment by investors.
TD stock trades at $115.10, up 1.08% with a bearish technical signal despite strong earnings beats in recent quarters. The company maintains solid profitability with 24.88% net income margin and 13.64% ROE, supported by a $10 billion share buyback announcement. Recent news highlights expansion plans including 100 new U.S. branches and a $108 billion commitment to Canadian infrastructure.
The outlook remains positive with analyst consensus favoring Buy ratings (52.94%) and consistent earnings outperformance, though technical indicators suggest near-term pressure. Key risks include volatile cash flows and rising debt-to-asset ratios, while institutional activity shows mixed sentiment with recent insider selling.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About Toronto-Dominion Bank
Toronto-Dominion is one of Canada's two largest banks and operates three business segments: Canadian retail banking, U.S. retail banking, and wholesale banking. The bank's U.S. operations span from Maine to Florida, with a strong presence in the Northeast. It also has a 13% ownership stake in Charles Schwab.
Read more on TD →
